Celeste R. Caulder, PharmD

Associate Professor :: International Director of Global Opportunity in Pharmacy

CPOS, South Carolina College of Pharmacy

803.777.4370 :: Columbia

803.434.2925 :: Palmetto Health Richland

Dr. Caulder's Email

Dr. Celeste Caulder

About Dr. Caulder

Dr. Caulder is an Associate Professor at the South Carolina College of Pharmacy in the Department of Clinical Pharmacy and Outcomes Sciences and a Clinical Pharmacist at Palmetto Health Richland who specializes in Medicine and Infectious Diseases. She was named the 2013 recipient of the Kappa Epsilon Merck Vanguard Leadership Award, which recognizes individuals for their accomplishments as a leader, encourages professional achievement among members and provides visibility as successful role models for young practitioners. Along with numerous publications (see link to full vita), Dr. Caulder also has a textbook published by McGraw Hill, Roadmap to Postgraduate Training.  

Research Interests

  • Infectious Diseases and HIV/AIDS 
  • Antimicrobial stewardship
  • Antimicrobial dosing in obesity 
  • Gram-positive and gram-negative infections

Practice Site/Specialty

Clinical Pharmacy Specialist
Infectious Diseases and Internal Medicine, Palmetto Health Richland


Global Initiative

Global Pharmacy
Dr. Caulder is the International Director
of Global Opportunity in Pharmacy.
Learn More

Dr. Caulder is the Program Coordinator for
Infectious Diseases PGY-2 Specialty Residency
& Infectious Clinical Fellowship.
Learn More



Doctor of Pharmacy
University of North Carolina (Chapel Hill) 2004

Infectious Diseases Specialty Residency, 2005-2006

University of Texas MD Anderson Cancer Center
University of Houston College of Pharmacy

Pharmacy Practice Residency, 2004-2005
University of Virginia Charlottesville, VA


  • Bosso JA, Nappi J, Rudisill C, Weillen M, Bookstaver B, Swindler J et al.  Relationship between vancomycin trough concentrations and and nephrotoxicity: a prospective multicenter trial.  Antimicrob Agents Chemother.  2011;55:5475-9.
  • Varner T, Bookstaver B, Rudisill C, Albrecht H.  The role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia.  Ann Pharmacother.  2011;45:967-76.
  • Bookstaver PB, Rudisill C, Bickley A, McAbee C, Miller A, Piro C et al. An evidence-medicine based elective course to improve student performance in advance pharmacy practice experiences.  Am J Pharm Educ.  2011;75(1):9.
  • Bookstaver PB, Miller A, Rudisill C, Norris L.  Intravenous ibuprofen: the first injectable product for treatment of pain and fever. J Pain Res.  2010;25:67-79.
  • Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL et al.  Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose combination daptomycin therapy.  Ann Pharmacother.  2010;44:2001-6.
  • Miller AD, Piro CC, Rudisill CN, Bookstaver PB, Bair JD, Bennet CL.  Nighttime and weekend medication error rates in an inpatient pediatric population.  Ann Pharmacother.  2010; 44:1739-46.
  • Riser MS, Bland CM, Rudisill CN, Bookstaver PB.  Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococus aureus meningitis.  Ann Pharmacother.  2010;44:1832-5.